| Name | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[1,3-benzodioxol-5-ylsulfonyl(2-methylpropyl)amino]-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate |
|---|---|
| Synonyms |
GW-640385X
brecanavir CHEMBL206031 Cbamic acid, N-[(1S,2R)-3-[(1,3-benzodioxol-5-ylsulfonyl)(2-methylpropyl)amino]-2-hydroxy-1-[[4-[(2-methyl-4-thiazolyl)methoxy]phenyl]methyl]propyl]-, (3R,3aS,6-hexahydrofuro[2,3-b]furan-3-yl ester GW0385 GW-640385 UNII-E367I8C7FI [(1R,5S,6R)-2,8-dioxabicyclo[3.3.0]oct-6-yl] N-[(2S,3R)-4-(benzo[1,3]dioxol-5-ylsulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]cbamate 2fdd GW-0385 2fde |
| Description | Brecanavir (GW640385) is a novel, potent HIV protease inhibitor. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.43g/cm3 |
|---|---|
| Molecular Formula | C33H41N3O10S2 |
| Molecular Weight | 703.82300 |
| Exact Mass | 703.22300 |
| PSA | 191.60000 |
| LogP | 5.33740 |
| Index of Refraction | 1.641 |